𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis

✍ Scribed by Lars Hagmar; Ulf Strömberg; Håkan Tinnerberg; Zoli Mikoczy


Book ID
114494558
Publisher
Elsevier Science
Year
2001
Tongue
German
Weight
62 KB
Volume
204
Category
Article
ISSN
1438-4639

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Nuclear morphometry as an intermediate e
✍ Neal Poulin; Iouri Boiko; Calum MacAulay; Charles Boone; Kenji Nishioka; Walter 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

The use of nuclear morphometry as an intermediate endpoint biomarker is described in a Phase I, dose-seeking trial of chemoprevention of cervical cancer, using the agent ␣-difluoromethylornithine (DFMO). Thirty patients with grade III cervical intraepithelial neoplasia (CIN III) were enrolled, and t

Oncogene proteins as biomarkers in the m
✍ Paul W. Brandt-Rauf 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 918 KB

The use of oncogene proteins as biomarkers offers a new approach to the molecular epidemiologic evaluation of occupational carcinogenesis. The ras oncogene-encoded p21 protein represents a prototype for this type of study, since it is known to be activated by common occupational carcinogens, is freq

Statistical validation of intermediate m
✍ Laurence S. Freedman; Arthur Schatzkin; Mark H. Schiffman 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

Using an intermediate marker of precancer as an endpoint for evaluating agents that may prevent cancer involves a presumption that the modification of the marker will be accompanied by a modification of cancer incidence. This presumption can hold only if the marker is on or very closely linked to a